11.06
+0.6(+5.74%)
Currency In USD
| Previous Close | 10.46 |
| Open | 10.75 |
| Day High | 11.08 |
| Day Low | 10.31 |
| 52-Week High | 24.5 |
| 52-Week Low | 8.89 |
| Volume | 269,711 |
| Average Volume | 596,086 |
| Market Cap | 479.44M |
| PE | -8.64 |
| EPS | -1.28 |
| Moving Average 50 Days | 15.15 |
| Moving Average 200 Days | 16.37 |
| Change | 0.6 |
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025
GlobeNewswire Inc.
Apr 16, 2025 8:05 PM GMT
IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2025 financial result
Beta Bionics to Host Investor Event on June 22, 2025
GlobeNewswire Inc.
Apr 09, 2025 11:30 AM GMT
IRVINE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced that it will host an investor event on Sunday, J
Beta Bionics Announces Board Appointment of Gerard Michel
GlobeNewswire Inc.
Mar 27, 2025 8:45 PM GMT
IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the appointment of Gerard Michel as an independent member of its